Aspas Requena G, Aguiar E, Brioso J, Ayala R, et al. Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry. Leukemia 2026 Oct 6. doi: 10.1038/s41375-026-03154.
PMID: 42839073